The global Glaucoma Aqueous Shunt market size is predicted to grow from US$ 1229 million in 2025 to US$ 2490 million in 2031; it is expected to grow at a CAGR of 12.5% from 2025 to 2031.
A glaucoma drainage implant is a small device placed in the eye to treat glaucoma. There are many different ways to treat glaucoma. In addition to conventional and laser surgery, there are a variety of drugs to lower intraocular pressure (IOP). If these methods alone fail, doctors may suggest implants.
It is understood that glaucoma is an irreversible blinding eye disease that is highly harmful and irreversible. Glaucoma brings heavy economic burdens and physiological and psychological distress to patients and society.
Glaucoma blindness is a chronic process. Early detection and reasonable and effective treatment can avoid blindness. Lowering intraocular pressure to treat open-angle glaucoma (POAG) is currently the only proven effective method to slow the progression of glaucoma. For every 1 mmHg decrease in intraocular pressure, the risk of glaucoma progression is reduced by 10%. The European, American and Asia-Pacific Glaucoma Associations as well as my country's glaucoma diagnosis and treatment guidelines all recommend the setting of target intraocular pressure. The main methods of treating glaucoma in my country include drugs, lasers and surgery. However, due to the complexity of risk factors, target intraocular pressures are not the same, and individuals have different responses to treatment. It has been reported that one-third of patients do not meet the target intraocular pressure, which means that they will find it difficult to maintain good vision and quality of life during their lifetime. Therefore, it is urgent to develop new methods to solve this problem. Internationally, new, minimally invasive, and biocompatible drainage devices provide more options and better solutions for glaucoma treatment.
Glaucoma aqueous shunts are implanted in the eye to establish a new aqueous humor outflow path from the anterior chamber (the area inside the eye filled with aqueous humor) to the subconjunctival space (the area between the sclera and conjunctiva). The aqueous humor is drained to the subconjunctival space through the shunt, forming a filtration bleb, thereby reducing the intraocular pressure
Market development trend
Technological innovation: With the continuous advancement of science and technology, glaucoma shunts will continue to introduce new technologies and new materials to improve product performance and safety. For example, the integration of intelligent technology will make glaucoma shunts more accurate and efficient.
Personalized treatment: With the improvement of medical level and the diversification of patient needs, personalized treatment will become an important development direction of the glaucoma shunt market. Enterprises need to provide customized products and services according to the specific conditions of patients to meet their personalized needs.
Internationalization strategy: With the development of global economic integration, the demand for glaucoma shunts in the international market is also increasing. Enterprises will strengthen international cooperation and expand overseas markets to achieve market expansion and global business layout.
LP Information, Inc. (LPI) ' newest research report, the “Glaucoma Aqueous Shunt Industry Forecast” looks at past sales and reviews total world Glaucoma Aqueous Shunt sales in 2024, providing a comprehensive analysis by region and market sector of projected Glaucoma Aqueous Shunt sales for 2025 through 2031. With Glaucoma Aqueous Shunt sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Glaucoma Aqueous Shunt industry.
This Insight Report provides a comprehensive analysis of the global Glaucoma Aqueous Shunt landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Glaucoma Aqueous Shunt portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Glaucoma Aqueous Shunt market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Glaucoma Aqueous Shunt and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Glaucoma Aqueous Shunt.
This report presents a comprehensive overview, market shares, and growth opportunities of Glaucoma Aqueous Shunt market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Trabecular Meshwork-Schlemm Canal Drainage
Subconjunctival Drainage
Others
Segmentation by Application:
Hospital
Ophthalmology Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
AbbVie
Santen Pharmaceutical
Johnson and Johnson
Advanced Ophthalmic Innovations (AOI)
New World Medical
Nova Eye Medical
Glaukos Corp
Alcon
iSTAR Medical
Henan Universe
Ocular Therapeutix
PolyActiva
Health Guard Biomed
Key Questions Addressed in this Report
What is the 10-year outlook for the global Glaucoma Aqueous Shunt market?
What factors are driving Glaucoma Aqueous Shunt market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Glaucoma Aqueous Shunt market opportunities vary by end market size?
How does Glaucoma Aqueous Shunt break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook